# Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer

> **NCT07311317** · — · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 165 (estimated)

## Conditions studied

- Breast Cancer Early Stage Breast Cancer (Stage 1-3)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07311317
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07311317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07311317, "Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07311317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*